Open access chemical and clinical probes to support drug discovery

被引：79

作者：

Edwards, Aled M. ^{[1
]}

Bountra, Chas ^{[2
]}

Kerr, David J. ^{[3
]}

Willson, Timothy M. ^{[4
]}

机构：

[1] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada

[2] Univ Oxford, Struct Genom Consortium, Oxford, England

[3] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar

[4] GlaxoSmithKline, Discovery Med Chem, Res Triangle Pk, NC USA

来源：

NATURE CHEMICAL BIOLOGY | 2009年 / 5卷 / 07期

基金：

加拿大健康研究院; 英国惠康基金;

关键词：

ORPHAN NUCLEAR RECEPTORS; SUBSTANCE-P; SYNOVIAL-FLUID; PAIN; BRADYKININ; INHIBITORS; ARTHRITIS; GENOMICS;

D O I：

10.1038/nchembio0709-436

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.

引用

页码：436 / 440

页数：5

共 26 条

[1] Development of farnesyl transferase inhibitors: A review [J].

Appels, NMGM ;

Beijnen, JH ;

Schellens, JHM .

ONCOLOGIST, 2005, 10 (08) :565-578

[2] Experimental human muscle pain induced by intramuscular injections of bradykinin, serotonin, and substance P [J].

Babenko, V ;

Graven-Nielsen, T ;

Svensson, P ;

Drewes, AM ;

Jensen, TS ;

Arendt-Nielsen, L .

EUROPEAN JOURNAL OF PAIN-LONDON, 1999, 3 (02) :93-102

[3]

Boyce S, 2000, PROG PAIN RES MANAG, V16, P313

[4] Nuclear receptors and lipid physiology: Opening the X-files [J].

Chawla, A ;

Repa, JJ ;

Evans, RM ;

Mangelsdorf, DJ .

SCIENCE, 2001, 294 (5548) :1866-1870

[5] Large-Scale Structural Biology of the Human Proteome [J].

Edwards, Aled .

ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :541-568

[6] MMPs as therapeutic targets - Still a viable option? [J].

Fingleton, Barbara .

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (01) :61-68

[7]

Garnier JP, 2008, HARVARD BUS REV, V86, P68

[8] Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists [J].

Gharat, Laxmikant A. ;

Szallasi, Arpad .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (02) :159-209

[9] Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway [J].

Gunthorpe, Martin J. ;

Chizh, Boris A. .

DRUG DISCOVERY TODAY, 2009, 14 (1-2) :56-67

[10] An index to quantify an individual's scientific research output [J].

Hirsch, JE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (46) :16569-16572

← 1 2 3 →